Given that skeletal muscle is a major site for glucose disposal, quantitative declines in muscle volume in patients with type 2 diabetes might adversely affect overall glucose metabolism; thus, insulin therapy could improve optimal glucose targets [52]. Here, INS is linked to type 2 diabetes mellitus.